{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/TSXV/PCRX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# PharmaCorp Rx Inc. (TSXV: PCRX) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is PharmaCorp Rx Inc., listed on the TSXV under the ticker PCRX. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. Its security type is Corporate, its sector is Life Sciences, and its segment and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 14 filings across 10 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 13 days, against a TSXV median of 19 days and a Life Sciences median of 17.5 days. The median latency is 16 days from the latest filing to the record date, against a TSXV median of 17.0 days and a Life Sciences median of 14 days. The latest filing is a newswire release dated 2026-10-21. The filings by type are 6 newswire releases, 4 halt and resume notices, 3 exchange bulletins and 1 corporate action.\n\n## Auditor\n\nThe auditor of record is MNP LLP, with its location not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds one lifecycle line, a listing dated 2025-11-13. It holds no delisting, domicile change, name change or segment move. The issuer is listed, not halted.\n\n## Orderability\n\nUnder the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, the outcome is determinable for both client categories, paragraph (o) of the definition and paragraph (q) of the definition, and each carries signal code ACM-200. The chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 3 research houses: Acumen Capital, Canaccord Genuity and Raymond James.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds no sealed years for this issuer, and the market's vintage is not sealed. The live record began on 2026-09-10. The store holds years 2021 through 2026 sealed but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSXV/PCRX (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- http://www.pharmacorprx.ca/wp-content/uploads/2025/09/PrelimProsp_PharmaCorp.pdf (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.pharmacorprx.ca/investors/ (coverage)\n- https://mcp.ca-cm-kg.ai/record/TSXV/PCRX (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "Tavily regex",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "http://www.pharmacorprx.ca/wp-content/uploads/2025/09/PrelimProsp_PharmaCorp.pdf",
    "state": "sourced",
    "value": "MNP LLP"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/TSXV/PCRX",
  "coverage": {
   "count": 3,
   "houses": [
    {
     "analyst": "Nick Corcoran",
     "house": "Acumen Capital",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharmacorprx.ca/investors/",
     "state": "sourced"
    },
    {
     "analyst": "Tania Armstrong-Whitworth",
     "house": "Canaccord Genuity",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharmacorprx.ca/investors/",
     "state": "sourced"
    },
    {
     "analyst": "Michael Glen",
     "house": "Raymond James",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.pharmacorprx.ca/investors/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.pharmacorprx.ca/investors/",
     "result": "read: 3 of 6 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1427,
     "median_cadence_gap_days": 19,
     "median_filings": 9,
     "median_latency_days": 17,
     "name": "TSXV"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "corporate_action": 1,
    "exchange_bulletin": 3,
    "halt_resume": 4,
    "newswire_release": 6
   },
   "cadence_median_gap_days": 13,
   "filing_days": 10,
   "filings": 14,
   "latency_days": 16,
   "latest": [
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.globenewswire.com/news-release/2026/10/21/3385744/0/en/pharmacorp-to-present-at-planet-microcap-toronto-2026-conference.html",
     "title": "PharmaCorp to Present at Planet Microcap Toronto 2026",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.globenewswire.com/news-release/2026/10/21/3385744/0/en/pharmacorp-to-present-as-planet-microcap-toronto-2026-conference.html",
     "title": "PharmaCorp to Present at Planet Microcap Toronto 2026",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-14",
     "source": "https://www.globenewswire.com/news-release/2026/10/14/3380622/0/en/pharmacorp-announces-cfo-transition-and-appointment-of-andrew-hodson-as-chief-financial-officer.html",
     "title": "PharmaCorp Announces CFO Transition and Appointment of",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-01",
     "source": "https://www.globenewswire.com/news-release/2026/10/01/3373439/0/en/pharmacorp-closes-two-previously-announced-acquisitions-and-provides-acquisition-pipeline-update.html",
     "title": "PharmaCorp Closes Two Previously Announced Acquisitions and",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-07-27",
     "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=320099&CORRECTION_FLG=N&HC_FLAG1=checked",
     "title": "TSXV bulletin: PROSPECTUS-UNIT OFFERING (Financings that are not done thru an Exchange Offering Prospectus)",
     "type": "exchange_bulletin"
    }
   ],
   "latest_filing_date": "2026-10-21",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/TSXV/PCRX",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "TSXV"
   },
   "isin": {
    "market": "CA",
    "reason": "no ISIN found on issuer pages",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "market": "CA",
    "reason": "none found",
    "state": "not_on_record"
   },
   "lei": {
    "market": "CA",
    "reason": "no ISIN",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "PharmaCorp Rx Inc."
   },
   "sector": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*",
    "state": "sourced",
    "value": "PCRX"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [
    {
     "date": "2025-11-13",
     "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=306211&CORRECTION_FLG=N&HC_FLAG1=checked",
     "title": "TSXV bulletin: NEW LISTING-WARRANTS (New Listings)"
    }
   ],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:f29dc6465165900cf445e60995f90957812d15c7774c3436eefbfa502ea501ef",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/TSXV/PCRX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:f29dc6465165900cf445e60995f90957812d15c7774c3436eefbfa502ea501ef",
 "path": "/ca/TSXV/PCRX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is PharmaCorp Rx Inc., listed on the TSXV under the ticker PCRX. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. Its security type is Corporate, its sector is Life Sciences, and its segment and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 14 filings across 10 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 13 days, against a TSXV median of 19 days and a Life Sciences median of 17.5 days. The median latency is 16 days from the latest filing to the record date, against a TSXV median of 17.0 days and a Life Sciences median of 14 days. The latest filing is a newswire release dated 2026-10-21. The filings by type are 6 newswire releases, 4 halt and resume notices, 3 exchange bulletins and 1 corporate action.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is MNP LLP, with its location not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one lifecycle line, a listing dated 2025-11-13. It holds no delisting, domicile change, name change or segment move. The issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, the outcome is determinable for both client categories, paragraph (o) of the definition and paragraph (q) of the definition, and each carries signal code ACM-200. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 3 research houses: Acumen Capital, Canaccord Genuity and Raymond James.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds no sealed years for this issuer, and the market's vintage is not sealed. The live record began on 2026-09-10. The store holds years 2021 through 2026 sealed but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*"
  },
  {
   "for": "identity.sector",
   "source": "https://www.tsx.com/en/resource/571"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/TSXV/PCRX"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the auditor",
   "source": "http://www.pharmacorprx.ca/wp-content/uploads/2025/09/PrelimProsp_PharmaCorp.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.pharmacorprx.ca/investors/"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/TSXV/PCRX"
  }
 ],
 "title": "PharmaCorp Rx Inc. (PCRX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}